CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot

January 15, 2019 updated by: Raymond KY Tong, Chinese University of Hong Kong

CUHK Jockey Club Tech-Based Stroke Rehabilitation Programme for Elderly Centre - Interactive Exoskeleton Ankle Robot

The Hong Kong Jockey Club Charities Trust has supported CUHK to launch a three-year project 'CUHK Jockey Club HOPE4Care Programme' to implement four evidence-based advanced rehabilitation technologies in 40 local elderly day care centres and rehabilitation centres, to benefit the community. The Exoskeleton Ankle Robot is a robot-assisted Ankle-Foot-Orthosis to facilitate gait training of person after stroke with drop foot.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • Department of Biomedical Engineering, The Chinese University of Hong Kong
        • Contact:
          • Raymond Tong, PhD
          • Phone Number: +852 3943 8454

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • have the ability to walk on the ground independently or with one personal assistance with or without walking aids
  • able to understand simple commends

Exclusion Criteria:

  • have other neurological, neuromuscular, and orthopedic diseases
  • uncontrolled cardiovascular or respiratory disorders
  • moderate to severe contractures in the lower extremities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ankle Group
Integrated with force and motion sensors to identify gait phase and classify user walking intention using machine learning control algorithm.
Provide sensory feedback to help subjects relearn how to walk in correct gait pattern.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Fugl-Meyer Assessment Lower Extremity (FMA-LE)
Time Frame: 3-month follow-up
3-month follow-up

Secondary Outcome Measures

Outcome Measure
Time Frame
Modified Ashworth Scale (MAS)
Time Frame: 3-month follow-up
3-month follow-up
Functional Ambulation Classification (FAC)
Time Frame: 3-month follow-up
3-month follow-up
Berg Balance Scale (BBS)
Time Frame: 3-month follow-up
3-month follow-up
Timed 10-Meter Walk Test (10MWT)
Time Frame: 3-month follow-up
3-month follow-up
6 Minute Walk Test (6MWT)
Time Frame: 3-month follow-up
3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2019

Primary Completion (Anticipated)

December 31, 2021

Study Completion (Anticipated)

December 31, 2021

Study Registration Dates

First Submitted

December 20, 2018

First Submitted That Met QC Criteria

January 15, 2019

First Posted (Actual)

January 17, 2019

Study Record Updates

Last Update Posted (Actual)

January 17, 2019

Last Update Submitted That Met QC Criteria

January 15, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Ankle Group

3
Subscribe